Ontology-based cross-species integration and analysis of Saccharomyces cerevisiae phenotypes by Gkoutos, Georgios V & Hoehndorf, Robert
PROCEEDINGS Open Access
Ontology-based cross-species integration and
analysis of Saccharomyces cerevisiae phenotypes
Georgios V Gkoutos1,2*, Robert Hoehndorf1,2
From Ontologies in Biomedicine and Life Sciences (OBML 2011)
Berlin, Germany. 6-7 October 2011
* Correspondence: gg295@cam.ac.
uk
1Department of Genetics,
University of Cambridge, Downing
Street, Cambridge, Cambridge CB2
3EH, UK
Abstract
Ontologies are widely used in the biomedical community for annotation and
integration of databases. Formal definitions can relate classes from different
ontologies and thereby integrate data across different levels of granularity, domains
and species. We have applied this methodology to the Ascomycete Phenotype
Ontology (APO), enabling the reuse of various orthogonal ontologies and we have
converted the phenotype associated data found in the SGD following our proposed
patterns. We have integrated the resulting data in the cross-species phenotype
network PhenomeNET, and we make both the cross-species integration of yeast
phenotypes and a similarity-based comparison of yeast phenotypes across species
available in the PhenomeBrowser. Furthermore, we utilize our definitions and the
yeast phenotype annotations to suggest novel functional annotations of gene
products in yeast.
Background
Yeast phenotypes have been proven useful for investigating and revealing various
aspects of cellular physiology and mechanisms. The study of these phenotypes has
direct implications for understanding mammalian physiology in the context of pharma-
codynamics and pharmacokinetics studies, in understanding signalling and regulatory
networks, in studies that focus on the identification of response regulators, activators
and inhibitors, and in chemical genetics [1-4]. It is therefore essential that efficient
ways are set in place to collect and analyse yeast phenotype data as well as compare
them with other organism phenotypes held in a variety of resources.
Over the last years, a plethora of phenotype ontologies has been proposed [5-11].
These ontologies are developed by a variety of biomedical communities and aim to
support the annotation of phenotypic observations derived either from the literature or
from experimental studies, including large scale phenotype studies [12,13]. To unify
the species-specific efforts in representing phenotypes, to enable the integration of phe-
notype information across species, and to enhance the formally represented genotype-
to-phenotype knowledge, a species and domain independent method for decomposing
phenotypes was proposed based on the Phenotype And Trait Ontology [14]. This
method has been successfully applied both for the direct annotation of species-specific
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phenotypes and for defining classes in species-specific phenotype ontologies to enable
cross-species phenotype integration [15-18].
The Saccharomyces Genome Database (SGD) [19] collects and curates yeast-related
phenotype data using the yeast-specific Ascomycete Phenotype Ontology (APO) [20].
Here, we report our efforts to apply the EQ-based method to the APO and enable the
reuse of biomedical reference ontologies to describe yeast-related phenotype informa-
tion as well as integrate it with other species. We apply the results of our analysis to
the cross-species phenotype network PhenomeNET [21] and make both the cross-
species integration of yeast phenotypes and a similarity-based comparison of yeast
phenotypes across species available in the PhenomeBrowser [22].
Materials and methods
Saccharomyces Genome Database
The Saccharomyces Genome Database (SGD) is a freely available collection of genetic
and molecular information about Saccharomyces cerevisiae. The SGD contains,
amongst others, sequence information for yeast genes and proteins as well as tools for
their analyses and comparison, descriptions of their biological roles and molecular
functions, the subcellular location at which proteins are active, literature information
and links to external resources [19].
In particular, SGD contains information about phenotypes that arise from curation of
either the published scientific literature of traditional bench experiments or from the
results of a number of large-scale studies [20]. Such information can be useful for
revealing new molecular functional information of genes and SGD curators currently
focus on its integration with the available genetic information [19]. The phenotype
information recorded includes developmental, metabolism and growth related, proces-
sual and morphological manifestations at the cellular level [20].
PATO
The Phenotype And Trait Ontology (PATO) was envisaged and designed to provide a
platform for allowing the integration of quantitative and qualitative phenotype related
information across different levels of granularity of domain knowledge granularity and
species [14]. PATO provides an ontology of phenotype related qualities that compro-
mise the basic entities that we can perceive and/or measure such as colors, sizes,
masses, lengths etc. Qualities inhere to entities: every entity comes with certain quali-
ties that exist as long as the entity exists. PATO allows for the description of affected
entities by combining various ontologies that describe the entities that have been
affected, such as the various anatomical ontologies, GO [23], the Cell Type Ontology
[24] or the Sequence Ontology (SO) [25], with the various qualities it provides for
defining how these entities were affected. PATO can be used for annotation either
directly in a so called post-composed (post-coordinated) manner or for providing logi-
cal definitions (equivalence axioms) to ontologies containing a set of precomposed
(pre-coordinated) phenotype terms. For instance, to describe a developmental delay
phenotype of yeast cell, we can combine the PATO term delayed (PATO:0000502)
with the GO term cellular development process (GO:0048869), whilst if such a term
existed in a precomposed ontology it could be used to provide an equivalence state-
ment between that class and the above PATO-based description.
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Annotating phenotypes using the Ascomycete Phenotype Ontology
The curation of yeast phenotype information is based on a combination of multiple
controlled vocabularies which are available from the OBO Foundry ontology repository
[26]. One of these vocabularies is the Ascomycete Phenotype Ontology (APO) that, as
of 30/06/2011, contains 269 terms organised in four hierarchies [20]. Sub-classes of
Experiment type provide a classification of genetic interactions and types of experi-
ments (assays) performed on yeast. The class Mutant type has sub-classes that provide
a classification of types of mutations in yeast that may cause a specific phenotype.
Finally, the observable and qualifier classes are used to record the actual phenotypic
observation [20]. The top-level classes of the APO are shown in Figure 1.
According to APO, the observable class corresponds to the feature or the trait of a
phenotype. For example, traits that can be sub-classes of the observable class include
the shape or size of a cell or the rate of a growth. These sub-classes are distinguished
based on the entity that is affected in a phenotype manifestation and based on the
trait that is affected. For example, classification based on the entity yields cellular pro-
cess, cell metabolism and cellular growth, while the classification based on traits results
in sub-classes such as cell morphology. The APO’s qualifier class, on the other hand,
provides a set of possible comparative values for these traits. For example, increased,
arrested and abnormal are included as sub-classes of APO’s qualifier class. In order to
annotate a phenotype corresponding to the observation of abnormal cell shape, the
APO class cell shape (APO:0000051) (a sub-class of observable) is combined with the
APO class abnormal (APO:0000002) (a sub-class of qualifier). APO terms can further
be used in conjunction with further ontologies, in particular the Chemical Entities of
Biological Interest (ChEBI) ontology [27] to extent their ability to describe phenotypes.
Results
To formally decompose APO’s phenotype classes based on the EQ method and enable
the integration of yeast phenotype annotations with phenotype annotations from other
species, we have used the PATO [14] and the Gene Ontology (GO) [23] as well as
Figure 1 Top-level of the Ascomycete Phenotype Ontology.
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ChEBI [27]. We apply different definition patterns for the different sub-classes of
APO’s observable.
Morphological traits
APO morphological characteristics are applicable to the morphology of either cellular
or sub-cellular structures. We have used the class Morphology (PATO:0000051) and
its subclasses, and we link them to the appropriate anatomical localisation provided by
GO’s cellular component branch. For example, to define the APO term Cell wall mor-
phology (APO:0000053), the GO cellular anatomical term Cell wall (GO:0005618)
is linked to the Morphology (PATO:0000051) term from the PATO ontology.
We implement this EQ-based definition in the OBO Flat file Format [28] following
the syntactic patterns associated with EQ [18]. In the OBO Flat file Format, the defini-
tion can be expressed as follows:
[Term]
id: APO:0000053 ! cell wall morphology
intersection_of: PATO:0000051 ! morphology
intersection_of: inheres_in GO:0005618
Formally, we use the conversion approach used in the PhenomeBLAST software [22]
to represent this syntactic description of a phenotype in OWL. PhenomeBLAST applies
a simplified form of the phene-patterns [29], and the Cell wall morphology phenotype
would be represented as a phenotype of entities that have a cell wall as part in which a
quality of the type Morphology inheres:
APO:0000053 EquivalentTo: phenotype-of some
(has-part some (GO:0005618 and
has-quality some PATO:0000051))
In some cases, the APO terms are related to temporal stages, i.e., the phenotypes are
observed only while the yeast cell is in a certain stage. For example, stages of the cell
cycle are used in classes such as Critical cell size at G2/M (cryptic G2/M cell size
checkpoint) (APO:0000142). To define a class involving reference to a temporal stage,
we use the during relation and a class from the GO. In the OBO Flat file Format, the
class Critical cell size at G2/M (cryptic G2/M cell size checkpoint) is defined as follows:
[Term]
id: APO:0000142
intersection_of: PATO:0000117 ! size
intersection_of: inheres_in GO:0005623
intersection_of: during GO:0031576
Formally, this phenotype is translated into the OWL definition:
APO:0000142 EquivalentTo: phenotype-of some
(has-part some (GO:0005623 and
has-quality some PATO:0000117 and
during some GO:0031576))
Developmental, metabolic and physiological phenotypes
The APO contains the classes Cellular process, Development, Metabolism and growth
as well as Interaction with host/environment. We assume that each of these classes
represents a phenotype that is based on a process. In particular, we use GO’s
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classification of processes to define the APO class Cellular process (APO:0000066) as
a phenotype of a Cellular process (GO:0009987), Development (APO:0000023) as a
phenotype of a Cellular developmental process (GO:0048869) and Metabolism and
growth (APO:0000094) as a phenotype of either Cellular metabolic process
(GO:0044237) or Cellular growth (GO:0016049). To obtain additional inferences
based on the parthood relations in the GO, we use definition patterns that include the
part-of relation, which we assume to be reflexive and transitive. For example, we for-
mally define Cellular process as:
APO:0000066 EquivalentTo: phenotype-of some
(has-part some (part-of some
GO:0009987 and has-quality some
PATO:0000001))
This definition pattern uses the has-part relation to relate an organism (the range of
phenotype-of) to a process. We do not use the participates-in relation for this pur-
pose, since explicitly distinguishing between processes and material objects will cur-
rently lead to contradictions in phenotype ontologies and the GO [30]. In the future,
we intend to explicitly incorporate more expressive phenotype definition patterns that
enable interoperability between ontologies of both anatomy and physiology [29].
To define APO classes that describe phenotypes associated with biological processes
or molecular functions, we linked the appropriate GO classes with terms from PATO.
The classification of biological processes or molecular functions in the GO provide the
entity affected by a phenotype while PATO characterizes how these entities are
affected.
As a consequence of defining the sub-classes of observable in APO based on the GO
using the part-of relation, we can infer a new and updated taxonomic structure of
APO in which Development and Metabolism and growth are sub-classes of Cellular
process. This inference is obtained through inference over GO’s classification of pro-
cesses and the definition patterns we provide.
Dispositional phenotypes
A common kind of phenotypes in yeast include dispositions to interact with other sub-
stances in a particular way. For example, the APO class Metal resistant (APO:0000090)
is used to describe yeast’s disposition to interact with metal.
In the EQ-based decomposition of the class Metal resistant, we use GO’s process class
Response to metal ion (GO:0010038) and combine it with the PATO class Sensitivity of a
process (PATO:0001457):
[Term]
id: APO:0000090
intersection_of: PATO:0001457
intersection_of: inheres_in GO:0010038
Similar to processual phenotypes, we do not yet use the has-disposition or has-
function relation in formalizing this phenotype because formally distinguishing
between functions and processes will lead to a large number of unsatisfiable class in
phenotype ontologies and the GO. Consequently, we formally define Metal resistant as:
APO:0000090 EquivalentTo: phenotype-of some
(has-part some (GO:0010038 and
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has-quality some PATO:0001457))
In the future, we intend to formalize dispositional phenotypes using the has-disposition
or has-function relation.
Interoperability with chemistry ontology
Relational classes from the PATO ontology can also be used to characterize qualities of
more than one entity. We use the towards relation to specify the second argument of a
relational quality. For example, we define the APO term Resistance to chemicals
(APO:0000087) by linking the class Chemical compound (CHEBI:37577) to the PATO
class Sensitivity of a process (PATO:0001457) and the process class Response to chemical
stimulus (GO:0042221):
[Term]
id: APO:0000087
intersection_of: PATO:0001457
intersection_of: inheres_in GO:0042221
intersection_of: towards CHEBI:37577
Formally, we express this statement as
APO:0000087 EquivalentTo: phenotype-of some
(GO:0042221 and
has-quality some (PATO:0001457 and
towards some CHEBI:37577))
Phenotypic qualifiers
To relate APO’s qualifier-classes to the PATO ontology, we created a statement of equiva-
lency between PATO’s qualifier classes and APO’s qualifier classes. For example, for the
APO term arrested (APO:0000250), we created an equivalent-class statement to the
PATO term arrested (PATO:0000297). Since PATO formally distinguishes between qua-
lities that inhere in objects and qualities that inhere in processes such statements also
allowed for reasoners to automatically check the consistency of the combination of quali-
fiers with anatomical or processual terms created by curators for annotation purposes.
Formalizing yeast phenotype annotations
The SGD makes phenotype annotations for specific genotypes and genetic interactions
available. These annotations consist of a genotype identifier (such as S000029075)
and either a pair or a triple of classes which describe the phenotype that is associated
with the genotype. If the phenotype annotation consists of a pair of classes, a class
from the APO’s observable branch is combined with a class from the APO’s qualifier
branch. For example, the genotype S000029075, a conditional mutation of the
CDC29 gene, has three phenotype annotations in the SGD:
• heat sensitivity (APO:0000147): increased (APO:0000004)
• budding (APO:0000024): absent (APO:0000005)
• cell cycle progression (APO:0000253): arrested (APO:0000250)
To formalize these phenotypes, we first identify the entity and the quality that is
affected in a phenotype. For example, Heat sensitivity (APO:0000147) is defined as a
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phenotype of a Response to heat (GO:0009408) process and is based on the PATO
quality Sensitivity of a process (PATO:0001457). Based on this information, we create
an OWL class expression. Since the qualifier that is applied to Heat sensitivity
(APO:0000147) is Increased (APO:0000004) and the quality Sensitivity of a process
(PATO:0001457), we construct an anonymous Increased sensitivity of a process class
using the increased-in-magnitude-relative-to (similarly to PATO’s definition of the
Increased sensitivity of a process class) (PATO:0001551)and formalize Heat sensitivity:
increased as:
phenotype-of some (has-part some
GO:0009408 and has-quality some
(PATO:0001457 and
increased-in-magnitude-relative-to some
normal))
Based on this information, the phenotype description will be inferred to be a sub-
class of APO’s Heat sensitivity, it will inter-operate with phenotypes that are based on
PATO’s Increased sensitivity of a process class (because they share the same definition)
and through inference over the GO we can obtain basic interoperability across multiple
species’ phenotype descriptions.
We formalize the phenotype “cell cycle progression: arrested” using the PATO term
Arrested (PATO:0000297) and the GO process class Cell cycle process
(GO:0022402):
phenotype-of some (has-part some
GO:0022402 and has-quality some
PATO:0000297)
We formalize the remaining phenotype description of S000029075 in a similar way
and combine the individual phenotype classes using class intersection.
Phenotype descriptions based on a triple consist of an entity, a qualifier and a second
entity that is used to define the respective phenotype class. For example, S000000649
is annotated with Ionic stress resistance: decreased and the additional class Sodium
chloride (CHEBI:26710). The intended meaning of this phenotype description is that
the resistance of the yeast cell to respond to sodium chloride is decreased within the
specific experiment that was performed. To formalize this phenotype, we combine the
PATO class Sensitivity of a process (PATO:0001457), the GO class Response to chemi-
cal stimulus (GO:0042221) and the ChEBI class Sodium chloride (CHEBI:26710):
phenotype-of some (has-part some
GO:0042221 and has-quality some
(PATO:0001457 and towards some
CHEBI:26710))
Using phenotypes to reveal gene functions
Our hypothesis is that phenotypes can be utilised to reveal the function of genes. For
example, when a gene is knocked out with a resulting developmental phenotypic mani-
festation we can assume that the gene plays some role in the development of the
organism. In order to validate our hypothesis and the applicability of our approach, we
tested it against our ability to reproduce known gene functions for the set of yeast
genes that we can recover phenotype data from SGD. We extracted the GO terms
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from the phenotype annotations and compared them against the GO annotation that
SGD has associated with the corresponding genes. We were able to recover 11% of the
GO processes annotations, 15% of the cell components annotations and 18% of the
GO functions annotations found in SGD. The GO annotations we infer from the phe-
notypes, that are not available for the SGD, present novel candidates annotations for
these gene products. For example, based on the curated single mutant phenotypes
associated with CLN3 that can be found in SGD, we were able to propose the gene’s
involvement in the regulation of the duration of G1 phase of mitotic cell cycle. Given
that G1 cyclin is involved in cell cycle progression and activates Cdc28p kinase to pro-
mote the G1 to S phase transition [31] our predicted association of the GO term G1
phase of mitotic cell cycle (GO:0000080) presents a novel possible GO annotation for
it.
Future research
Many of the definitions we propose do not make full use of established phenotype
definition patterns that enable interoperability with ontologies of functions and pro-
cesses [29,32]. However, our prime motivation in defining yeast phenotypes was to
enable cross-species phenotype integration and comparison using the PhenomeBLAST
and PhenomeNET methods. We have formally integrated the APO and the definitions
of the APO that we created with the ontology underlying PhenomeBLAST (the soft-
ware and ontology are available from http://phenomeblast.googlecode.com), and we
can represent yeast phenotypes using the phenotype ontologies that were created for
other species. For example, the phenotypes of S000029048 (annotated with the single
phenotype Autophagy: absent) expressed using the Mammalian Phenotype Ontology
(MP) are Abnormal metabolism, Homeostasis/metabolism phenotype and Mammalian
phenotype. Using the Worm Phenotype Ontology (WPO), which targets an organism
that is more similar to yeast than mammals, we obtain as phenotypes abnormalities of
Autophagy, Intracellular transport, Small molecule transport and Cellular processes.
In the future we intend to evaluate this work via utilizing our ability to integrate yeast
phenotypes with phenotype information from other species so as to identify interacting
proteins, orthologous genes and other evolutionary or biological meaningful relations.
Conclusion
In the future, we intend to evaluate the potential of yeast phenotype annotations to
predict orthologous genes and genes involved in metabolic diseases based on compari-
sons of phenotypes. Furthermore, as cross-species phenotype integration progresses,
we intend to update the definitions to accurately reflect more complex relations.
In the post-genomic era, the analysis and integration of phenotype data have been
demonstrated as useful tools assigning genotype to phenotype correlations, providing
insights in the nature of human disease and ultimately discovering novel therapeutic
approaches. The challenge now remains to provide mechanisms and methods that
allow such integration and analysis on a large scale that takes into account the vast
amount of phenotypic information collected around the world for various species in a
single framework. One such framework has been proposed based on the use of PATO
and a variety of external ontologies [33] and has been successfully demonstrated to
work for achieving such integration [15-18].
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Here we demonstrated how yeast phenotype information could be defined based on
this framework and we have successfully included yeast phenotype data in a cross spe-
cies phenotype data network. As such yeast phenotype data can be integrate and man-
alysed with data from other species and increases their potential for discovering new
genotype to phenotype correlations.
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